Market Tracker

09/19 6:35pm ET

Geron Corp (NASDAQ:GERN)

2.25
Data as of Sep 19
 -0.06 / -2.60%
Today’s Change
1.31
Today|||52-Week Range
7.36
-49.76%
Year-to-Date

Today’s Trading

Previous close2.31
Today’s open2.31
Day’s range2.19 - 2.34
Volume4,186,723
Average volume (3 months)2,702,552
Market cap$353.1M
Dividend yield--
Data as of 3:59pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)+44.44%
Earnings growth (this year)+24.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.64%
P/E ratioNM
Price/Sales474.30
Price/Book4.92

Competitors

 Today’s
change
Today’s
% change
OXFDOxford Immunotec Glo...+0.12+0.85%
TRIBTrinity Biotech PLC-0.10-0.49%
DNDNDendreon Corp+0.08+5.63%
TTHITransition Therapeut...-0.02-0.31%
Data as of 3:59pm ET, 09/19/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.3M
Annual profit (last year)-$38.4M
Net profit margin-2,991.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts